2022 Award Winners

The ICIS-Pfizer Award for Excellence in Interferon and Cytokine Research (formerly the Seymour & Vivian Milstein Award) The ICIS-Pfizer Award for Excellence in Cytokine & Interferon Research (formerly the Seymour and Vivian MILSTEIN Award), represents the pinnacle of scientific achievement in cytokine & interferon research. This Award is bestowed upon [READ MORE]

Lydia Lynch, PhD, Principle Investigator, Associate Immunologist, Brigham and Women’s Hospital/ Harvard Medical School, Director, Metabolic Core, Brigham and Women’s Hospital, Boston, USA

The 2022 ICIS-Luminex John R. Kettman Award for Excellence in Cytokine & Interferon Research Mid-career recognizes Lydia Lynch’s outstanding contributions to the field of cytokine biology, innate lymphoid cells, and established leadership in the field of immunometabolism. [READ MORE]

Ludmila (Mila) Prokunina-Olsson has been chosen for the 2022 ICIS Mentorship Award in recognition of her significant contributions to the field of immunity and cancer genetics through not only her own seminal discoveries and scientific accomplishments but also through the next generation of scientists she has nurtured, taught and guided. Dr. Prokunina-Olsson’s admiration for diversity and ability to recognize potential, particularly in minority scientists, and then develop a trajectory for their success, have played an important role in establishing the careers of her fellows who then go on to become mentors themselves. [READ MORE]

Luke O’Neill is honored with the 2022 ICIS Honorary Lifetime Membership Award in recognition of his exemplary service to the ICIS s a scientific participant, prize winner and organizer at many of our meetings, as well as his public service. Luke has also been a tremendous public advocate for immunology over the course of the COVID-19 pandemic and most recently has been helping to raise support and get needed supplies to Ukraine. [READ MORE]

Curt M. Horvath is honored with the 2022 ICIS-Distinguished Service Award in recognition of his reputation in the community as both an outstanding cytokine scientist and a remarkably dedicated member of the ICIS. Dr. Horvath has long served on the ICIS council (2014 until present) from his first term being instrumental in facilitating the unification of the ICS and ISICR, helping to find common ground among challenging territorial disputes between the two societies. In his current Council term he initiated discussion on inclusion of young investigators in the ICIS leadership and advocated for creation of new council seats to include our newest members in ICIS leadership, based on inclusion and training which is already making an impact on the Cytokines annual meeting program organization and diversity goals. He is known for mentoring interactions with diverse groups of junior faculty, postdocs, and graduate students, participating in Networking Workshops for Young Investigators, and is a regular and enthusiastic participant in spontaneous ICIS jam sessions. [READ MORE]

David Artis and Wanjun Chen are jointly recognized for the 2022 ICIS-BioLegend William E. Paul Award for their combined contributions to unraveling the exciting and important biology of cytokines. David Artis’ work has pushed the boundaries of conventional approaches to immune defenses, and elucidated the important role of cytokines in host defenses at the barrier surfaces of the gut, skin, and lungs. Wanjun Chen’s work has significantly advanced our understanding of pathogenesis and has led to the development of immunotherapies for autoimmunity, cancer, and infectious diseases. [READ MORE]

Professor Yoshimura has been chosen as the 2022 ICIS-Pfizer Award for Excellence in Cytokine & Interferon Research, the society’s most prestigious award, in recognition of his outstanding discoveries in the field of cytokine biology that have transformed human medicine. Professor Yoshimura’s ground breaking discoveries have played an important role in inflammation, allergy, autoimmune diseases, and tumor immunity, improving our understanding of the pathogenesis of inflammatory diseases. [READ MORE]